These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 23664031)

  • 41. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
    Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
    Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular invasion is an adverse prognostic factor in resected non-small-cell lung cancer.
    Ramnefjell M; Aamelfot C; Helgeland L; Akslen LA
    APMIS; 2017 Mar; 125(3):197-206. PubMed ID: 28233448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ; Han F; Gao SL; A DL; Pang ZL
    Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Validity and controversies in the new postoperative pathologic TNM classification based on the results of surgical treatment of non-small cell lung cancer].
    Hosokawa Y; Matsuge S; Murakami Y; Satoh K; Yamazaki S; Kan T; Hatakeyama H
    Kyobu Geka; 2000 Oct; 53(11):910-4. PubMed ID: 11048440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].
    Ma K; Wang TY; He BL; Chang D; Gong M
    Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):670-3. PubMed ID: 18956719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic impact of preoperative tumor marker levels and lymphovascular invasion in pathological stage I adenocarcinoma and squamous cell carcinoma of the lung.
    Kinoshita T; Ohtsuka T; Yotsukura M; Asakura K; Goto T; Kamiyama I; Otake S; Tajima A; Emoto K; Hayashi Y; Kohno M
    J Thorac Oncol; 2015 Apr; 10(4):619-28. PubMed ID: 25634009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer.
    Yip PY; Cooper WA; Kohonen-Corish MR; Lin BP; McCaughan BC; Boyer MJ; Kench JG; Horvath LG
    J Clin Pathol; 2014 Apr; 67(4):333-40. PubMed ID: 24265323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Establishment and evaluation of a prognostic prediction model for patients after complete resection of non-small cell lung cancer and multidisciplinary therapy].
    Wei WD; Fu JH; Lin P; Li XD; Yang H; Rong TH; Chen LK
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):672-5. PubMed ID: 19173908
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical impact of the use of the revised International Association for the Study of Lung Cancer staging system to operable non-small-cell lung cancers.
    Lyons G; Quadrelli S; Jordan P; Colt H; Chimondeguy D
    Lung Cancer; 2011 Nov; 74(2):244-7. PubMed ID: 21411177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulatory T-cells and micrometastasis in lymph nodes of stage I NSCLC.
    Hanagiri T; Fukumoto M; Koyanagi Y; Furutani Y; Tanaka F
    Anticancer Res; 2014 Dec; 34(12):7185-90. PubMed ID: 25503147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of clinical and pathological tumor, node and metastasis staging of lung cancer: 15-year experience with 530 patients.
    Turk F; Gursoy S; Yaldiz S; Yuncu G; Yazgan S; Basok O
    Minerva Chir; 2011 Dec; 66(6):509-16. PubMed ID: 22233657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
    Ito M; Yamashita Y; Miyata Y; Ohara M; Tsutani Y; Ikeda T; Misumi K; Harada H; Omori K
    Lung Cancer; 2012 Apr; 76(1):93-7. PubMed ID: 22285532
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of blood vessel invasion on prognosis of operated stage I non-small cell lung cancer patients.
    Turhan K; Samancilar O; Cagirici U; Goksel T; Nart D; Cakan A; Cok G
    Thorac Cardiovasc Surg; 2010 Feb; 58(1):28-31. PubMed ID: 20072973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer ? A multivariate prognostic factor analysis of 151 patients.
    Ichinose Y; Hara N; Ohta M; Yano T; Maeda K; Asoh H; Katsuda Y
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):90-4. PubMed ID: 8391613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Verification of the newly proposed T category (seventh edition of the tumor, node, and metastasis classification) from a clinicopathological viewpoint in non-small cell lung cancer-special reference to tumor size.
    Yano T; Morodomi Y; Ito K; Yoshida T; Haro A; Shoji F; Koga T; Maehara Y
    J Thorac Oncol; 2010 Jan; 5(1):45-8. PubMed ID: 19884855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic significance of blood and lymphatic vessel invasion in pathological stage IA lung adenocarcinoma in the 8th edition of the TNM classification.
    Samejima J; Yokose T; Ito H; Nakayama H; Nagashima T; Suzuki M; Hamanaka R; Yamada K; Masuda M
    Lung Cancer; 2019 Nov; 137():144-148. PubMed ID: 31593845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer.
    Noma D; Inamura K; Matsuura Y; Hirata Y; Nakajima T; Yamazaki H; Hirai Y; Ichinose J; Nakao M; Ninomiya H; Mun M; Nakagawa K; Masuda M; Ishikawa Y; Okumura S
    Clin Lung Cancer; 2018 Jan; 19(1):e109-e122. PubMed ID: 29066222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.